1.Meta-analysis of the efficacy and safety of Saccharomyces boulardii versus Bifidobacterium triple live bacteria in the treatment of pediatric diarrhea
Xiaodan ZHANG ; Ruiqin WANG ; Lu LIU ; Meijuan REN ; Meixing YAN
China Pharmacy 2024;35(2):226-230
		                        		
		                        			
		                        			OBJECTIVE To compare the efficacy and safety of Saccharomyces boulardii and Bifidobacterium triple live bacteria in the treatment of pediatric diarrhea. METHODS Retrieved from PubMed, Embase, the Cochrane Library, CBM, Wanfang data, CNKI and VIP, randomized controlled trials (RCTs) about S. boulardii (S. boulardii group) versus Bifidobacterium triple liver bacteria (Bifidobacterium group) were collected. After screening the literature, extracting data and evaluating the quality, meta-analysis was performed by using RevMan 5.3 software. RESULTS A total of 9 RCTs were included, involving 898 patients. Results of meta-analysis showed there was no statistical significance in total response rate [OR=1.69, 95%CI (0.93, 3.09), P=0.09], duration of diarrhea [MD=-1.39, 95%CI (-3.35, 0.57), P=0.16], the time of abdominal pain disappearance [MD=0.09, 95%CI(-0.87, 1.05),P=0.86] or the incidence of adverse reactions [OR=0.65, 95%CI (0.05, 8.03), P=0.74]. The number of stools in S. boulardii group was significantly less than Bifidobacterium group [MD=-0.91, 95%CI (-1.80, -0.02), P=0.04]. The results of subgroup analysis showed that the duration of diarrhea in children with antibiotic-associated diarrhea in S. boulardii group was significantly shorter than Bifidobacterium group (P<0.05). CONCLUSIONS The efficacy and safety of S. boulardii are similar to those of Bifidobacterium in the treatment of diarrhea, but S. boulardii is better than Bifidobacterium in terms of stool number, the duration of diarrhea in children with antibiotic-associated diarrhea.
		                        		
		                        		
		                        		
		                        	
2.Meta-analysis of the safety of polysaccharide iron complex versus ferrous sulfate in the treatment of anemia during pregnancy
Guangyan WANG ; Lu LIU ; Qiaoli WANG ; Meixing YAN ; Chang LIU
China Pharmacy 2023;34(13):1627-1631
		                        		
		                        			
		                        			OBJECTIVE To compare the safety of polysaccharide iron complex and ferrous sulfate in the treatment of anemia during pregnancy. METHODS Retrieved from Cochrane Library, PubMed, Embase, SinoMed, CNKI, VIP and Wanfang database, randomized controlled trials (RCTs) about polysaccharide iron complex (trial group) versus ferrous sulfate (control group) in the treatment of anemia during pregnancy were collected from the inception to May 20th, 2022. After literature screening, data extraction and quality evaluation, meta-analysis, sensitivity analysis and publication bias analysis were conducted with RevMan 5.3 software. RESULTS A total of 13 RCTs were included, with a total of 1 318 patients. Results of meta-analysis showed that the total incidence of adverse drug reactions (ADR) [RR=0.11, 95%CI (0.06, 0.18), P<0 000 01], gastrointestinal adverse reactions [RR=0.08, 95%CI (0.05, 0.12), P<0.000 01], anorexia and nausea [RR=0.21, 95%CI (0.09, 0.54), P= 0.001], abdominal pain [RR=0.18, 95%CI (0.04, 0.78), P=0.02], diarrhea [RR=0.18, 95%CI (0.04, 0.79), P=0.02], vomiting [RR=0.24, 95%CI (0.06, 0.89), P=0.03] and gingival melanosis [RR=0.09, 95%CI (0.03, 0.28), P<0.000 1] in the trial group were all significantly lower than the control group. The results of sensitivity analysis showed that the conclusions obtained in this study were relatively robust. The results of publication bias analysis indicated that there was a high possibility of publication bias in this study. CONCLUSIONS The polysaccharide iron complex is safer than ferrous sulfate for treatment of anemia during pregnancy.
		                        		
		                        		
		                        		
		                        	
3.Consensus on prescription review of commonly used H 1-antihistamines in pediatrics
Lihua HU ; Lu LIU ; Huiying CHEN ; Heping CAI ; Wentong GE ; Zhiying HAN ; Huijie HUANG ; Xing JI ; Yuntao JIA ; Lingyan JIAN ; Nannan JIANG ; Zhong LI ; Li LI ; Hua LIANG ; Chuanhe LIU ; Qinghong LU ; Xu LU ; Jun′e MA ; Jing MIAO ; Yanli REN ; Yunxiao SHANG ; Kunling SHEN ; Huajun SUN ; Jinqiao SUN ; Yanyan SUN ; Jianping TANG ; Hong WANG ; Lianglu WANG ; Xiaochuan WANG ; Lei XI ; Hua XU ; Zigang XU ; Meixing YAN ; Yong YIN ; Shengnan ZHANG ; Zhongping ZHANG ; Xin ZHAO ; Deyu ZHAO ; Wei ZHOU ; Li XIANG ; Xiaoling WANG
Chinese Journal of Applied Clinical Pediatrics 2023;38(10):733-739
		                        		
		                        			
		                        			H 1-antihistamines are widely used in the treatment of various allergic diseases, but there are still many challenges in the safe and rational use of H 1-antihistamines in pediatrics, and there is a lack of guidance on the prescription review of H 1-antihistamines for children.In this paper, suggestions are put forward from the indications, dosage, route of administration, pathophysiological characteristics of children with individual difference and drug interactions, so as to provide reference for clinicians and pharmacists.
		                        		
		                        		
		                        		
		                        	
4.Recommendations for prescription review of commonly used anti-seizure medications in treatment of children with epilepsy
Qianqian QIN ; Qian DING ; Xiaoling LIU ; Heping CAI ; Zebin CHEN ; Lina HAO ; Liang HUANG ; Yuntao JIA ; Lingyan JIAN ; Zhong LI ; Hua LIANG ; Maochang LIU ; Qinghong LU ; Xiaolan MO ; Jing MIAO ; Yanli REN ; Huajun SUN ; Yanyan SUN ; Jing XU ; Meixing YAN ; Li YANG ; Shengnan ZHANG ; Shunguo ZHANG ; Xin ZHAO ; Jie DENG ; Fang FANG ; Li GAO ; Hong HAN ; Shaoping HUANG ; Li JIANG ; Baomin LI ; Jianmin LIANG ; Jianxiang LIAO ; Zhisheng LIU ; Rong LUO ; Jing PENG ; Dan SUN ; Hua WANG ; Ye WU ; Jian YANG ; Yuqin ZHANG ; Jianmin ZHONG ; Shuizhen ZHOU ; Liping ZOU ; Yuwu JIANG ; Xiaoling WANG
Chinese Journal of Applied Clinical Pediatrics 2023;38(10):740-748
		                        		
		                        			
		                        			Anti-seizure medications (ASMs) are the main therapy for epilepsy.There are many kinds of ASMs with complex mechanism of action, so it is difficult for pharmacists to examine prescriptions.This paper put forward some suggestions on the indications, dosage forms/routes of administration, appropriateness of usage and dosage, combined medication and drug interaction, long-term prescription review, individual differences in pathophysiology of children, and drug selection when complicated with common epilepsy, for the reference of doctors and pharmacists.
		                        		
		                        		
		                        		
		                        	
5.Construction of standardized training system for medication direction provided by pediatric pharmacists
Canhui CHEN ; Meixing YAN ; Shujuan SUN ; Xiaoling WANG ; Suxin QU
China Pharmacy 2022;33(24):3053-3058
		                        		
		                        			
		                        			OBJECTIVE To explore the establishment of standardized training system for medication direction provided by pediatric pharmacists. METHODS Based on the questionnaire, the current needs of pediatric pharmacists and parents of children for medication direction were investigated, and the standardized training content of pediatric medication direction was constructed as a whole with reference to the survey results, instructions, databases and other literature. The basic knowledge of medication direction was integrated and summarized from the basic information of drugs such as drug name, usage and dosage, as well as the course of treatment, order of medication and special precautions, so as to form the general introduction of training content. In accordance with the principle of “integrated drug classification based on diseases”, a standardized framework of medication direction for various common diseases in children was constructed to form various theories of training content. Concomitantly, the pilot training of pharmacists in Qingdao Women and Children’s Hospital of Qingdao University was carried out, and the training effect was preliminarily evaluated. RESULTS After standardized training, the daily examination scores of pharmacists in this hospital were significantly higher than those before training, and the situation of ‘0’ times of receiving patients’ thank-you letters in the window service was broken through; the effective satisfaction rate of window service showed an increasing trend; after the pharmacist explained the medication to the patient, the times of patient returning to consult the doctor on how to use the medicine showed downward trend. CONCLUSIONS The establishment and implementation of a systematic standardized training system for pediatric-specialist pharmacists can help to further improve the professional skills and professionalism of pharmacists, strengthen the standardization of window medication direction and enhance patients’ sense of gain.
		                        		
		                        		
		                        		
		                        	
6.Recommendations for prescription review of antipyretic-analgesics in symptomatic treatment of children with fever
Xiaohui LIU ; Xing JI ; Lihua HU ; Yuntao JIA ; Huajun SUN ; Qinghong LU ; Shengnan ZHANG ; Ruiling ZHAO ; Shunguo ZHANG ; Yanyan SUN ; Meixing YAN ; Lina HAO ; Heping CAI ; Jing XU ; Zengyan ZHU ; Hua XU ; Jing MIAO ; Xiaotong LU ; Zebin CHEN ; Hua CHENG ; Yunzhu LIN ; Ruijie CHEN ; Xin ZHAO ; Zhenguo LIU ; Junli ZHANG ; Yuwu JIANG ; Chaomin WAN ; Gen LU ; Hengmiao GAO ; Ju YIN ; Kunling SHEN ; Baoping XU ; Xiaoling WANG
Chinese Journal of Applied Clinical Pediatrics 2022;37(9):653-659
		                        		
		                        			
		                        			Antipyretic-analgesics are currently one of the most prescribed drugs in children.The clinical application of antipyretic-analgesics for children in our country still have irrational phenomenon, which affects the therapeutic effect and even poses hidden dangers to the safety of children.In this paper, suggestions were put forward from the indications, dosage form/route, dosage suitability, pathophysiological characteristics of children with individual differences and drug interactions in the symptomatic treatment of febrile children, so as to provide reference for the general pharmacists when conducting prescription review.
		                        		
		                        		
		                        		
		                        	
7.Expression of Tspan29 in breast cancer tissues and its effect on malignant biological behaviors of MCF-7 and MDA-MB-231 cells
LI Gang ; WANG Meixing ; YANG Mei ; DANG Xuefei ; LI Xueqing ; LI Xiaojing ; WANG Hongxia
Chinese Journal of Cancer Biotherapy 2020;27(1):42-49
		                        		
		                        			
		                        			Objective: To investigate the expression of tetraspanins-29 (Tspan29) in breast cancer tissues and cell lines and to explore the effect of Tspan29 knockdown on proliferation, invasion, migration and epithelial-mesenchymal transition (EMT) of breast cancer MCF-7 and MDA-MB-231 cells. Methods:Atotal of20pairsofbreast cancer tissues and corresponding para-cancerous tissues resected in Minhang Branch of Cancer HospitalAffiliated to Fudan University from June 2017 to February 2018 were collected for this study; in addition, breast cancer celllinesMCF-7,MDA-MB-231andhumanbreastepithelialMDA-kb2cellswerealsocollected.ThemRNAand protein expressions of Tspan29 in above mentioned tissues and cell lines were detected by Real-time quantitative (qPCR) and Western blotting. The expression of Tspan29 in MCF-7 and MDA-MB-231 cells was interfered by siRNA. qPCR was used to detect the mRNA and protein expressions of Tspan29. PCR microarray was used to examine the expressions of EMT-related genes in MCF-7 cells. CCK-8 assayandTranswellwereusedtodetectcellproliferation, migration and invasion of MCF-7 and MDA-MB-231 cells. Results: The mRNA and protein expressions of Tspan29 in breast cancer tissues were significantly higher than that in para-cancerous tissues (all P<0.01); and the mRNA and protein expressions of Tspan29 in MCF-7 and MDA-MB-231 cells were significantly higher than that in MDA-kb2 cells (P<0.01). After being interfered with siTspan29, the mRNA and protein expressions of Tspan29 were significantly down-regulated in MCF-7 cells (all P<0.05); the proliferation, invasion and migration of MCF-7 and MDA-MB-231 cells were significantly inhibited (all P<0.05); and among the EMT-related genes, two were significantly up-regulated while 7 were down-regulated. Conclusion: Tspan29 is significantly up-regulated in breast cancer tissues and cell lines, and knockdown of Tspan29 significantly inhibits the proliferation, invasion and migration of breast cancer cells. 
·· 
		                        		
		                        		
		                        		
		                        	
8.Retrospective Analysis of 530 Cases of New/Severe Pediatric ADR in Shandong Province during 2016-2017
Ruiqin WANG ; Yanfei HUO ; Yanjun XIE ; Meixing YAN
China Pharmacy 2019;30(1):115-119
		                        		
		                        			
		                        			OBJECTIVE: To analyze the characteristics and regularity of new/severe pediatric ADR in Shandong province, and to promote the safe use of drugs in children. METHODS: A retrospective analysis of new/severe pediatric ADR in the Shandong Provincial ADR database 2016-2017 was conducted in respects of children’s gender and age, primary disease, ADR history, family ADR history, dosage form, route of administration, drug type, systems/organs involved in ADR, clinical manifestations, off-label drug use, drug combination, occurrence time, effects of ADR on primary disease, outcome, etc. RESULTS: A total of 44 742 pediatric ADR cases were collected from Shandong province ADR database from 2016 to 2017, including 27 060 male, 17 664 female and 18 gender unknown. 530 cases were diagnosed as new/severe pediatric ADR, including 334 male and 196 female with ratio of male to female 1.70 ∶ 1. New/severe ADR reports of children aged 1-3 took up the highest proportion (158 cases, 29.81%). Primary diseases were mainly respiratory disease (190 cases, 25.85%); there were 10 children with ADR history (1.89%), 2 with family ADR history (0.38%). Dosage forms were mainly injection (358 cases, 67.55%). Route of administration were mainly intravenous drip (431 cases, 81.32%). The drugs that caused ADR included 20 categories and 162 species, mainly including drug for regulating hydroelectric acid-base balance (148 cases caused by 8 kinds of drugs, 27.92%), antibiotics (89 cases caused by 33 kinds of drugs, 16.79%), traditional Chinese medicine and its extract (80 cases caused by 24 kinds of drugs, 15.09%). The systems/organs involved in ADR were mainly systemic injury (201 cases, 37.92%, main clinical manifestations included chills and fever, etc.), followed by skin and its appendants (99 cases, 18.68%, mainly clinical manifestations included rash and itching, etc.), respiratory system (76 cases, 14.43%, main clinical manifestations included dyspnea and cough, etc.). Off-label drug use were found in 41 cases (7.74%), including the safety of drug use was not clear in drug instructions (20 cases, 3.77%); no drug testing was carried out and no reliable references were available (13 cases, 2.45%), that medicine was prohibited was stated in drug instructions (2 cases, 0.38%). 106 cases (20.00%) had drug combination, including combined use of two drugs, three drugs and four drugs (62, 36, 8 cases). ADR occurred mainly within 0-5 min (140 cases, 26.42%). Among 530 children, ADR had no obvious effect on the outcome of the disease in 457 cases (86.23%); ADR caused longer course of disease in 57 cases (10.75%). 278 cases (52.45%) were cured and 243 cases (45.85%) were recovered. CONCLUSIONS: It is necessary to strengthen the monitoring of drug use in children, formulate national standards and relevant laws and regulations for children’s rational drug use, improve the awareness of medical staff to children’s ADR, strengthen the education and publicity of the knowledge about safe drug use in children, and to promote rational drug use.
		                        		
		                        		
		                        		
		                        	
9. Analysis of serious adverse drug reactions in 2016 from Qingdao of Shandong province
Chun FAN ; Tao WANG ; Meixing YAN
Chinese Journal of Primary Medicine and Pharmacy 2018;25(9):1181-1184
		                        		
		                        			 Objective:
		                        			To analyze characteristics of serious adverse drug reaction from Qingdao and provide reference for clinical applications.
		                        		
		                        			Methods:
		                        			1 130 reports collected by Qingdao Center for ADR Monitoring in 2016 were analyzed using retrospective study method.
		                        		
		                        			Results:
		                        			The antibiotics, traditional Chinese medicine injection and antitumor drug caused the higher proportion of serious adverse drug reaction.Injection was the main way for administration, which induced 73.45% of serious adverse drug reaction.65.00% cases with allergic shock occurred within 10min.Levofloxacin lactate injection caused the highest proportion of serious adverse drug reaction, Danhong injection caused the highest proportion of allergic shock reaction, Reduning injection caused the highest proportion of serious adverse drug reaction in children.
		                        		
		                        			Conclusion
		                        			Safety monitoring for antibiotics, traditional Chinese medicine injection and antitumor drug should be further strengthened, including children adverse reactions. 
		                        		
		                        		
		                        		
		                        	
10.Expression, purification of nattokinase in Pichia pastoris and preparation of its polyclonal antibody
Litao CAI ; Xiang XU ; Tingting WANG ; Meixing YU ; Yanyan YANG
Chinese Journal of Biochemical Pharmaceutics 2010;31(1):10-13
		                        		
		                        			
		                        			Purpose To indicate the expression of nattokinase (NK) in Pichia pastoris , an emulsion was prepared with the purified NK to prepare polyclonal antibody. In order to establish sandwich enzyme-linked immunosorbent assay (ELISA) to assay NK in organism, furthermore to lay the foundation for researching in vivo metabolism and function of NK. Methods The NK gene was cloned into a Pichia pastoris expression vector pHBM905A to construct the recombinant plasmid pPRONK.The recipient cell of Pichia pastoris GS115 was transformed with pPRONK which had been cut by restriction enzyme Sal I , under the induction of methanol. The expressed production is purified by salting out and ultrafiltration membrane. An emulsion was prepared with the purified NK and injected into rabbits to prepare polyclonal antibody. Results NK was expressed and identified by SDS-PAGE.The molecular mass of expressed production is about 27 kD.The fibrin plate assay indicated that the NK protein can cleavage fibrin effectively. ELISA analysis indicated that the polyclonal antibody titer is about 1:8 000. Western blot demonstrated that there was a special strap nearby 27 kD. Conclusion NK was successfully expressed in Pichia pastoris , the production can cleavage fibrin effectively and it had great immunogenicity.
		                        		
		                        		
		                        		
		                        	
            
Result Analysis
Print
Save
E-mail